Search

everythinglearnresearchcommunity

for

Search:↓

Quercetin may help with PCOS symptoms, but more research is needed.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

CD98hc's role in skin health decreases with age.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Hirsutism causes significant psychological distress in women.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Excess androgens may cause PCOS, not just be a symptom.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Early NAS level changes affect alcohol consumption vulnerability.